Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
13.34
Dollar change
+0.52
Percentage change
4.06
%
Index- P/E- EPS (ttm)-1.93 Insider Own46.19% Shs Outstand31.85M Perf Week-11.19%
Market Cap519.33M Forward P/E8.29 EPS next Y1.61 Insider Trans1.83% Shs Float20.95M Perf Month-27.38%
Income-55.41M PEG- EPS next Q-0.03 Inst Own34.78% Short Float16.01% Perf Quarter7.41%
Sales514.91M P/S1.01 EPS this Y265.38% Inst Trans-8.71% Short Ratio2.94 Perf Half Y4.06%
Book/sh-1.28 P/B- EPS next Y87.21% ROA-8.12% Short Interest3.35M Perf Year273.67%
Cash/sh4.31 P/C3.10 EPS next 5Y0.90% ROE-584.21% 52W Range2.89 - 19.56 Perf YTD3.89%
Dividend Est.- P/FCF- EPS past 5Y-35.30% ROI-29.44% 52W High-31.80% Beta1.65
Dividend TTM- Quick Ratio0.65 Sales past 5Y-27.17% Gross Margin87.52% 52W Low361.59% ATR (14)1.26
Dividend Ex-Date- Current Ratio0.65 EPS Y/Y TTM77.16% Oper. Margin-1.99% RSI (14)38.69 Volatility7.10% 9.08%
Employees2213 Debt/Eq- Sales Y/Y TTM-14.05% Profit Margin-10.76% Recom2.33 Target Price18.17
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q140.77% Payout- Rel Volume1.46 Prev Close12.82
Sales Surprise0.73% EPS Surprise160.87% Sales Q/Q-7.05% EarningsMar 15 BMO Avg Volume1.14M Price13.34
SMA20-18.64% SMA50-15.14% SMA20013.14% Trades Volume1,660,322 Change4.06%
Date Action Analyst Rating Change Price Target Change
Oct-13-23Initiated ROTH MKM Buy $30
Jul-15-22Resumed Goldman Sell $12.10 → $11
Jun-28-21Resumed Barclays Underweight
Mar-01-21Upgrade JP Morgan Underweight → Neutral $23 → $48
Jan-04-21Resumed Barclays Underweight $18
Jun-17-20Reiterated DA Davidson Buy $23 → $32
Jan-17-20Upgrade UBS Neutral → Buy $3.50
Dec-17-19Downgrade Goldman Neutral → Sell $3.20 → $2.40
Nov-06-19Downgrade JP Morgan Neutral → Underweight
Feb-04-19Initiated Goldman Neutral $3.50
Mar-18-24 10:47AM
Mar-16-24 09:19AM
Mar-15-24 10:24PM
06:34PM
11:52AM
10:43AM Loading…
10:43AM
08:31AM
07:36AM
07:05AM
Mar-12-24 07:19AM
Feb-28-24 08:30AM
Feb-23-24 11:34AM
Feb-06-24 06:29PM
Feb-04-24 11:01AM
Jan-22-24 08:31AM
08:50AM Loading…
Jan-15-24 08:50AM
Jan-12-24 08:47AM
Nov-23-23 03:49PM
Nov-21-23 04:01PM
Nov-10-23 04:40PM
01:54PM
01:01PM
11:17AM
10:58AM
09:57AM
02:20AM
Nov-09-23 06:55PM
04:06PM
04:05PM
Nov-02-23 02:49PM
10:00AM Loading…
Oct-26-23 10:00AM
06:15AM
Oct-25-23 06:16AM
Oct-24-23 07:15AM
01:32AM
Oct-23-23 09:20AM
08:50AM
Oct-16-23 07:01PM
Oct-13-23 04:47PM
01:20PM
09:50AM
01:49AM
Oct-12-23 09:01AM
Oct-10-23 01:31PM
Sep-08-23 03:00PM
11:30AM
Aug-31-23 06:58PM
Aug-28-23 01:12AM
Aug-24-23 12:06PM
11:38AM
Aug-15-23 06:25PM
Aug-13-23 09:38AM
Aug-11-23 11:35AM
Aug-10-23 09:02PM
10:47AM
10:12AM
06:53AM
Aug-09-23 07:55PM
06:43PM
04:10PM
Aug-08-23 04:01PM
09:07AM
Aug-03-23 09:56PM
Jul-23-23 08:52AM
Jul-20-23 03:41PM
Jul-07-23 09:10AM
Jun-09-23 11:30AM
Jun-08-23 08:50AM
May-24-23 06:34AM
May-14-23 02:39PM
May-11-23 01:09PM
01:09PM
12:23PM
May-10-23 08:05PM
06:54PM
04:42PM
May-03-23 10:00AM
Apr-26-23 09:02AM
Apr-13-23 12:48PM
10:06AM
09:03AM
Mar-31-23 02:21PM
07:45AM
Mar-20-23 03:02AM
Mar-19-23 08:55AM
Mar-18-23 08:50AM
Mar-17-23 01:05PM
12:25PM
Mar-16-23 06:35PM
05:49PM
04:45PM
Mar-15-23 08:34AM
Mar-14-23 09:16AM
Mar-10-23 07:30AM
Mar-09-23 08:46AM
Mar-02-23 05:10PM
Feb-13-23 05:30AM
Jan-31-23 12:43PM
06:19AM
Dec-21-22 05:33PM
Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Senkypl DusanInterim CEONov 20 '23Buy9.74137,9461,343,4277,040,310Nov 20 06:27 PM
Senkypl DusanInterim CEONov 17 '23Buy9.5024,803235,6166,902,364Nov 20 06:27 PM
Senkypl DusanInterim CEONov 16 '23Buy9.28160,5951,490,7026,877,561Nov 20 06:27 PM
Senkypl DusanInterim CEOAug 21 '23Option Exercise6.00437,5002,625,000449,112Aug 23 05:08 PM
Netzly KyleInterim CAOAug 20 '23Option Exercise0.003,422010,267Aug 21 05:19 PM
Netzly KyleInterim CAOMay 20 '23Option Exercise0.003,20607,655May 23 03:59 PM
Last Close
Mar 28 04:00PM ET
137.92
Dollar change
+0.09
Percentage change
0.07
%
NBIX Neurocrine Biosciences, Inc. daily Stock Chart
Index- P/E56.76 EPS (ttm)2.43 Insider Own2.60% Shs Outstand98.70M Perf Week-4.05%
Market Cap13.72B Forward P/E20.25 EPS next Y6.81 Insider Trans-22.52% Shs Float96.92M Perf Month2.42%
Income249.70M PEG3.15 EPS next Q1.06 Inst Own93.26% Short Float2.56% Perf Quarter3.89%
Sales1.89B P/S7.27 EPS this Y104.58% Inst Trans-1.47% Short Ratio2.89 Perf Half Y19.45%
Book/sh22.61 P/B6.10 EPS next Y34.76% ROA8.71% Short Interest2.48M Perf Year43.06%
Cash/sh10.37 P/C13.30 EPS next 5Y18.00% ROE12.68% 52W Range89.04 - 148.37 Perf YTD4.68%
Dividend Est.- P/FCF37.95 EPS past 5Y62.04% ROI10.03% 52W High-7.04% Beta0.24
Dividend TTM- Quick Ratio2.40 Sales past 5Y34.77% Gross Margin96.95% 52W Low54.90% ATR (14)4.20
Dividend Ex-DateDec 29, 1995 Current Ratio2.45 EPS Y/Y TTM57.90% Oper. Margin20.92% RSI (14)49.84 Volatility3.63% 3.06%
Employees1400 Debt/Eq0.21 Sales Y/Y TTM26.76% Profit Margin13.23% Recom1.68 Target Price152.22
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q63.53% Payout0.00% Rel Volume1.43 Prev Close137.83
Sales Surprise-0.64% EPS Surprise18.81% Sales Q/Q25.05% EarningsFeb 07 BMO Avg Volume859.74K Price137.92
SMA200.05% SMA500.42% SMA20017.78% Trades Volume1,229,474 Change0.07%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Resumed Citigroup Neutral $127
Dec-12-23Initiated Deutsche Bank Buy $136
Oct-24-23Resumed Cantor Fitzgerald Overweight $135 → $140
Aug-21-23Reiterated Mizuho Neutral $112 → $113
Jul-24-23Upgrade SVB Securities Market Perform → Outperform $115 → $125
Jul-06-23Upgrade BMO Capital Markets Underperform → Market Perform $91 → $96
May-04-23Upgrade Guggenheim Neutral → Buy $145
Mar-30-23Upgrade Canaccord Genuity Hold → Buy $124 → $132
Mar-03-23Upgrade Evercore ISI In-line → Outperform $130
Feb-03-23Upgrade Morgan Stanley Equal-Weight → Overweight $120 → $130
Mar-28-24 08:30AM
Mar-24-24 09:19AM
Mar-23-24 08:00AM
Mar-16-24 08:00AM
01:23AM
01:23AM Loading…
01:23AM
Mar-15-24 10:00AM
Mar-13-24 01:26AM
Mar-11-24 04:01PM
01:12PM
Mar-06-24 04:45PM
Mar-01-24 12:40AM
Feb-27-24 04:01PM
Feb-22-24 11:28PM
03:55AM
11:36PM Loading…
Feb-15-24 11:36PM
Feb-10-24 10:18AM
12:14AM
Feb-09-24 02:23AM
Feb-08-24 09:13AM
12:20AM
Feb-07-24 09:30AM
07:33AM
07:18AM
07:00AM
Feb-05-24 09:16AM
Feb-02-24 11:02PM
Jan-31-24 10:00AM
Jan-24-24 11:02PM
06:54AM
09:38AM Loading…
Jan-22-24 09:38AM
Jan-17-24 04:16PM
Jan-12-24 09:35AM
Jan-11-24 09:02PM
Jan-10-24 09:24AM
Jan-05-24 02:02AM
Jan-02-24 04:01PM
Dec-26-23 06:56PM
07:22AM
Dec-25-23 08:23PM
Dec-20-23 04:54AM
Dec-16-23 01:01PM
Dec-15-23 02:30PM
Dec-12-23 03:05PM
Dec-10-23 11:15AM
Dec-09-23 11:05AM
Dec-06-23 03:01AM
Dec-05-23 04:01PM
Dec-02-23 05:06AM
Dec-01-23 07:00AM
Nov-30-23 05:04AM
Nov-13-23 06:07PM
07:00AM
Nov-09-23 04:01PM
Nov-08-23 04:05PM
04:01PM
Nov-06-23 09:45AM
Nov-02-23 08:30AM
Nov-01-23 06:34PM
Oct-31-23 09:30AM
08:32AM
08:15AM
07:05AM
07:00AM
Oct-24-23 10:00AM
Oct-20-23 11:43AM
Oct-18-23 11:13AM
Oct-16-23 12:53PM
Oct-10-23 04:01PM
Oct-05-23 11:41AM
07:00AM
03:01AM
Oct-03-23 12:45PM
Sep-26-23 04:32PM
Sep-21-23 09:15AM
Sep-14-23 07:04PM
08:30AM
Sep-12-23 04:05PM
12:18PM
07:30AM
Sep-11-23 07:01PM
08:30AM
Sep-06-23 08:00AM
Aug-31-23 04:01PM
Aug-29-23 08:30AM
Aug-28-23 08:30AM
Aug-27-23 08:53AM
Aug-18-23 04:34PM
Aug-13-23 05:49PM
Aug-02-23 03:53PM
Aug-01-23 09:30AM
08:25AM
07:25AM
07:00AM
Jul-26-23 10:02AM
Jul-25-23 10:01AM
01:33AM
Jul-24-23 09:53AM
Jul-18-23 08:31AM
Jul-11-23 04:05PM
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Delaet IngridChief Regulatory OfficerMar 21 '24Option Exercise103.525,000517,60012,507Mar 25 06:02 PM
Delaet IngridChief Regulatory OfficerMar 21 '24Sale145.065,000725,3207,507Mar 25 06:02 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Option Exercise80.9075,0006,067,628110,299Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Option Exercise39.7940,0001,591,60020,000Mar 15 05:25 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Sale139.3875,00010,453,41740,778Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Sale139.4240,0005,576,7100Mar 15 05:25 PM
POPS RICHARD FDirectorMar 13 '24Option Exercise42.7623,200992,03252,712Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Option Exercise106.023,000318,06010,507Mar 15 05:15 PM
POPS RICHARD FDirectorMar 13 '24Sale140.3323,2003,255,62129,512Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Sale140.143,000420,4197,507Mar 15 05:15 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Option Exercise106.0220021,2047,707Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Option Exercise42.761004,27629,612Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Sale140.0020028,0007,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Sale140.0010014,00029,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Option Exercise106.021,800190,8369,307Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Option Exercise42.761,70072,69231,212Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Sale140.031,800252,0537,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Sale140.051,700238,07829,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Option Exercise79.0227321,5727,780Feb 29 07:02 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Sale135.5127336,9947,507Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Option Exercise53.6775,0004,025,04393,759Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Option Exercise79.026,544517,10710,007Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Sale134.6975,00010,101,60840,616Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Sale135.346,544885,6387,507Feb 29 07:02 PM
Norwalk Leslie VDirectorFeb 27 '24Option Exercise84.958,000679,6008,000Feb 29 06:50 PM
Norwalk Leslie VDirectorFeb 27 '24Sale135.678,0001,085,3880Feb 29 06:50 PM
POPS RICHARD FDirectorFeb 20 '24Option Exercise12.9815,000194,70044,512Feb 22 05:11 PM
POPS RICHARD FDirectorFeb 20 '24Sale132.4715,0001,987,04729,512Feb 22 05:11 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Option Exercise39.285,090199,951512,052Feb 14 05:17 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Sale133.022,832376,700514,596Feb 15 05:43 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 13 '24Sale133.071,811240,9964,895Feb 15 05:33 PM
Onyia JudeChief Scientific OfficerFeb 13 '24Sale132.941,432190,37113,128Feb 15 05:48 PM
Gano KyleChief Business Development OffFeb 13 '24Sale132.891,352179,674135,166Feb 15 05:40 PM
ABERNETHY MATTChief Financial OfficerFeb 13 '24Sale132.851,352179,61231,528Feb 15 05:27 PM
ROBERTS EIRYChief Medical OfficerFeb 13 '24Sale132.961,114148,12223,716Feb 15 05:51 PM
BENEVICH ERICChief Commercial OfficerFeb 13 '24Sale133.011,098146,05040,616Feb 15 05:29 PM
Lippoldt DarinChief Legal OfficerFeb 13 '24Sale132.991,098146,02839,740Feb 15 05:45 PM
Cooke JulieChief Human Resources OfficerFeb 13 '24Sale133.04796105,90217,976Feb 15 05:35 PM
Delaet IngridChief Regulatory OfficerFeb 13 '24Sale133.0371695,2537,507Feb 15 05:38 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 08 '24Sale134.152,274305,052506,962Feb 08 07:21 PM
Cooke JulieChief Human Resources OfficerFeb 08 '24Sale135.441,329179,99517,263Feb 08 07:35 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 08 '24Sale135.411,328179,8304,895Feb 08 07:46 PM
ABERNETHY MATTChief Financial OfficerFeb 08 '24Sale134.21980131,52930,314Feb 08 07:12 PM
ROBERTS EIRYChief Medical OfficerFeb 08 '24Sale134.21980131,52222,717Feb 08 07:28 PM
Gano KyleChief Business Development OffFeb 08 '24Sale134.20980131,519133,952Feb 08 07:17 PM
BENEVICH ERICChief Commercial OfficerFeb 08 '24Sale134.19980131,50939,631Feb 08 07:15 PM
Lippoldt DarinChief Legal OfficerFeb 08 '24Sale134.24911122,28938,755Feb 08 07:25 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 06 '24Sale142.183,040432,218504,919Feb 08 07:21 PM
Gano KyleChief Business Development OffFeb 06 '24Sale142.201,600227,522133,072Feb 08 07:17 PM
ABERNETHY MATTChief Financial OfficerFeb 06 '24Sale142.191,280182,00029,434Feb 08 07:12 PM
BENEVICH ERICChief Commercial OfficerFeb 06 '24Sale142.121,280181,91038,751Feb 08 07:15 PM
Cooke JulieChief Human Resources OfficerFeb 06 '24Sale142.071,215172,61717,263Feb 08 07:35 PM
ROBERTS EIRYChief Medical OfficerFeb 06 '24Sale142.241,121159,44621,837Feb 08 07:28 PM
Lippoldt DarinChief Legal OfficerFeb 06 '24Sale142.171,041147,99537,939Feb 08 07:25 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 06 '24Sale141.9645664,7344,894Feb 08 07:46 PM
Delaet IngridChief Regulatory OfficerFeb 01 '24Sale139.7762387,0776,865Feb 02 07:14 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 31 '24Sale140.692,707380,845502,188Feb 02 07:21 PM
Boyer David W.Chief Corp. Affairs OfficerJan 31 '24Sale140.802,096295,1154,894Feb 02 07:07 PM
Cooke JulieChief Human Resources OfficerJan 31 '24Sale141.291,740245,84217,263Feb 02 07:11 PM
Gano KyleChief Business Development OffJan 31 '24Sale140.701,541216,813131,635Feb 02 07:17 PM
ROBERTS EIRYChief Medical OfficerJan 31 '24Sale140.791,457205,13220,832Feb 02 07:29 PM
ABERNETHY MATTChief Financial OfficerJan 31 '24Sale140.721,283180,53928,284Feb 02 07:00 PM
Lippoldt DarinChief Legal OfficerJan 31 '24Sale140.651,250175,81037,005Feb 02 07:24 PM
BENEVICH ERICChief Commercial OfficerJan 31 '24Sale140.781,207169,92737,601Feb 02 07:05 PM
Delaet IngridChief Regulatory OfficerJan 31 '24Sale141.9442259,8996,309Feb 02 07:14 PM
Onyia JudeChief Scientific OfficerJan 31 '24Sale141.9412617,88411,843Feb 02 07:26 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Option Exercise79.0210,000790,20045,882Jan 24 05:47 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Sale139.8610,0001,398,55335,882Jan 24 05:47 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Option Exercise19.5962,0231,215,031561,777Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Sale134.0162,0238,311,895499,754Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Option Exercise19.59105,8352,073,308605,589Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Sale132.44105,83514,016,523499,754Jan 10 04:31 PM
Gano KyleChief Business Development OffJan 02 '24Option Exercise19.5975,0001,469,250199,134Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Option Exercise12.9820,000259,60062,785Jan 04 06:26 PM
Gano KyleChief Business Development OffJan 02 '24Sale131.4775,0009,860,194130,250Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Sale131.4711,0441,451,92751,741Jan 04 06:26 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Option Exercise73.0424,0001,752,90031,263Dec 27 04:08 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Sale128.6624,0003,087,80817,263Dec 27 04:08 PM
LYONS GARY ADirectorDec 22 '23Sale130.0410,0001,300,443193,697Dec 27 04:10 PM
ROBERTS EIRYChief Medical OfficerDec 22 '23Sale126.7410,0001,267,44819,521Dec 27 04:15 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Option Exercise81.0513,9251,128,62136,499Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Sale120.3013,9251,675,24029,521Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Option Exercise81.0530024,31529,721Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Sale120.1030036,03129,521Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Option Exercise78.5277,3796,076,12068,243Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Sale120.3777,3799,314,31929,521Dec 11 06:18 PM
Lippoldt DarinChief Legal OfficerDec 06 '23Option Exercise43.2420,830900,68956,712Dec 08 06:23 PM
ROBERTS EIRYChief Medical OfficerDec 06 '23Option Exercise77.818,396653,29337,917Dec 08 07:09 PM
Lippoldt DarinChief Legal OfficerDec 06 '23Sale119.8620,8302,496,64835,882Dec 08 06:23 PM
ROBERTS EIRYChief Medical OfficerDec 06 '23Sale120.038,3961,007,78029,521Dec 08 07:09 PM
LYONS GARY ADirectorDec 01 '23Option Exercise12.985,00064,900208,697Dec 05 04:54 PM
LYONS GARY ADirectorDec 01 '23Sale116.775,000583,837203,697Dec 05 04:54 PM
Onyia JudeChief Scientific OfficerNov 29 '23Sale113.572,331264,73311,732Dec 01 05:41 PM
Lippoldt DarinChief Legal OfficerNov 27 '23Sale112.2710,9191,225,91135,882Nov 29 04:36 PM
Boyer David W.Chief Corp. Affairs OfficerOct 02 '23Sale112.681,437161,9214,894Oct 04 05:07 PM
LYONS GARY ADirectorSep 12 '23Option Exercise12.985,00064,900208,697Sep 14 04:51 PM
LYONS GARY ADirectorSep 12 '23Sale115.025,000575,120203,697Sep 14 04:51 PM
LYONS GARY ADirectorSep 01 '23Option Exercise12.985,00064,900208,697Sep 06 04:25 PM
LYONS GARY ADirectorSep 01 '23Sale110.065,000550,316203,697Sep 06 04:25 PM
Cooke JulieChief Human Resources OfficerSep 01 '23Sale110.9382491,40617,263Sep 06 04:22 PM